Scholarlink

<p>Type&#xa0;1 interferonopathies are rare, mostly inherited disorders of the innate immune system in which uncontrolled type&#xa0;1 interferon production leads to inappropriate inflammatory processes. Based on pathogenetic findings, Janus kinase inhibitors represent a&#xa0;potential targeted treatment option.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Januskinase-Inhibitoren bei Interferonopathien

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月18日

查看全文
  • Andrea Skrabl-Baumgartner,
  • M. Lee-Kirsch

摘要

Type 1 interferonopathies are rare, mostly inherited disorders of the innate immune system in which uncontrolled type 1 interferon production leads to inappropriate inflammatory processes. Based on pathogenetic findings, Janus kinase inhibitors represent a potential targeted treatment option.